Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Perfusion Index Variability During Epidural Labor Analgesia

16. September 2026 aktualisiert von: Tomasz Jasiński, Medical University of Gdansk

Variability of the Peripheral Perfusion Index (PI) During Epidural Analgesia for Labor: A Single-Centre Prospective Observational Study

This prospective, single-centre observational study evaluates changes in the peripheral Perfusion Index (PI) - a non-invasive parameter derived from the pulse-oximetry photoplethysmographic waveform - in women receiving epidural, or combined spinal-epidural (CSE) with intrathecal opioid only, analgesia during vaginal labor. Epidural-induced sympathetic block causes vasodilation and compensatory changes in peripheral vascular resistance, which alter peripheral perfusion and therefore PI. PI is recorded together with routinely monitored haemodynamic, obstetric and analgesia-related variables (including pain intensity on the Numeric Rating Scale, NRS) from before block placement until after delivery. The aims are: to describe the pattern and magnitude of PI changes during labor analgesia and the parameter's usefulness in this dynamic clinical setting; to assess the correlation between PI changes and reported pain; and to evaluate whether PI (its change or the absence of change) can help identify ineffective blocks early - for example those caused by catheter malposition or by sacral sparing in the second stage of labor. All measurements are non-invasive and consistent with the current standard of perinatal care.

Studienübersicht

Detaillierte Beschreibung

Background: The Perfusion Index (PI) is the ratio of the pulsatile (AC) to the non-pulsatile (DC) component of light absorption in the photoplethysmographic waveform recorded during pulse oximetry, expressed as a percentage. Originally used as an indicator of pulse-oximeter signal quality, PI is now recognised as a non-invasive measure of peripheral perfusion. Because both signal components are influenced chiefly by vascular tone and vascular-bed filling, PI changes across clinical states. Spontaneous vaginal labor involves changes in cardiac output, peripheral resistance and blood redistribution, and therefore in PI. Neuraxial (epidural) analgesia further modifies PI: the sympathetic block it produces causes vasodilation and compensatory changes in peripheral resistance in non-blocked regions, altering peripheral perfusion. These changes can be captured systemically by the finger pulse oximeter routinely used to monitor labor analgesia. Analysing PI during epidural monitoring may therefore provide clinically useful information about correct block placement, drug distribution in the epidural space across successive stages of labor, and thus analgesic effectiveness.

Design and population: Prospective observational study. Participants are patients admitted to the labor ward of the Department of Obstetrics and Gynaecology, Gynaecologic Oncology and Gynaecologic Endocrinology, University Clinical Centre in Gdańsk, who receive epidural analgesia during vaginal delivery - either as the sole regional technique or as combined spinal-epidural (CSE) analgesia. For CSE, only intrathecal opioids may be administered (the standard approach in these patients); intrathecal local anaesthetic is an exclusion criterion. Both spontaneous-onset and induced labors are eligible.

Recorded haemodynamic parameters: PI is recorded automatically together with peripheral oxygen saturation (SpO2). Additional parameters recorded with standard monitors are arterial blood pressure, maternal heart rate (HR) and fetal heart rate (FHR). Monitoring begins before placement of the regional block.

Measurement schedule: Parameters are recorded every 5 minutes for the first 30 minutes after administration of local anaesthetic (LA) into the epidural space, and every 15 minutes thereafter. When bolus LA doses are given into the epidural space, 5-minute recording is resumed for 30 minutes from the time of administration. Data are archived as printouts from the labor-ward telemetry system.

Regional block data: The type of block and the doses/volumes and concentrations of all administered drugs are recorded with exact times. For drugs given by infusion, the flow rate per unit time and the time range for each rate are recorded.

Additional clinical data: Ramsay sedation score; correct block function assessed by cold sensation test; pain intensity on the Numeric Rating Scale (NRS); motor block on the Bromage scale; stage of labor and cervical dilation; body position; and any need to adjust catheter depth or replace the catheter. When reported pain exceeds NRS 4, pain location is additionally recorded. Intravenous drugs and fluids (dose and time), obstetric data (operative vaginal delivery with forceps or vacuum, episiotomy, conversion to caesarean section) and basic demographics (age, gestational week, number of previous pregnancies) are recorded, together with relevant comorbidities and medications to allow later subgroup analyses. Data are archived on a dedicated form or in the patient's anaesthesia chart.

Recording duration: Recording runs from before placement of the regional block until 30 minutes after delivery. If delivery is completed by caesarean section, recording continues until the patient is transferred to the operating room.

Non-invasive nature and standard of care: All recorded parameters are obtained non-invasively. PI - the study's object of interest - is recorded with the pulse oximeter that forms part of standard monitoring of patients receiving regional labor analgesia. The scope and frequency of monitoring are consistent with the applicable Polish organisational standard of perinatal care and with the procedures of the University Clinical Centre in Gdańsk.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

200

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • Pomeranian Voivodeship
      • Gdansk, Pomeranian Voivodeship, Polen, 80-322
        • University Clinical Centre in Gdańsk , Drpartment of Anesthesiology nd Intensive Therapy and Department of Obstetrics and Gynaecology, Gynaecologic Oncology and Gynaecologic Endocrinology
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Weiblich

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Women in spontaneous or induced vaginal labor, admitted to the labor ward of the Department of Obstetrics and Gynaecology, Gynaecologic Oncology and Gynaecologic Endocrinology, University Clinical Centre in Gdańsk, who receive epidural or opioid-only combined spinal-epidural analgesia.

Beschreibung

Inclusion Criteria:

  1. Use of epidural analgesia (epidural block, or combined spinal-epidural block) during spontaneous vaginal delivery.
  2. Signed informed consent to participate in the study.

Exclusion Criteria:

Administration of local anaesthetic into the intrathecal (subarachnoid) space as part of combined spinal-epidural analgesia.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: COHORT
  • Zeitperspektiven: PROSPECTIVE

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Women receiving epidural labor analgesia

Patients in spontaneous or induced vaginal labor receiving epidural analgesia as the sole regional technique, or combined spinal-epidural analgesia with intrathecal opioid only.

Neuraxial labor analgesia administered as part of routine care; local anaesthetic ± opioid via the epidural catheter (bolus and/or infusion), with exact drugs, doses, concentrations, volumes, infusion rates and times recorded. In the CSE subgroup only intrathecal opioid is given (intrathecal local anaesthetic is excluded).

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in peripheral Perfusion Index (PI) during epidural labor analgesia
Zeitfenster: From before neuraxial block placement until 30 minutes after delivery (typically up to several hours of labor).

Peripheral Perfusion Index (%), recorded non-invasively from a finger pulse oximeter, tracked across the course of labor. PI is recorded before block placement and then every 5 minutes for the first 30 minutes after epidural local-anaesthetic administration, every 15 minutes thereafter, with 5-minute recording resumed for 30 minutes after each epidural bolus. The pattern and magnitude of PI change relative to the pre-block baseline are assessed.

From before neuraxial block placement until 30 minutes after delivery (typically up to several hours of labor).

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Correlation between Perfusion Index change and pain intensity (NRS
Zeitfenster: From before neuraxial block placement until 30 minutes after delivery.

Association between changes in PI and self-reported pain intensity on the Numeric Rating Scale (NRS, 0-10) during epidural labor analgesia. NRS ≤ 4 is regarded as acceptable analgesia; pain location is additionally recorded when NRS > 4.

Unit of Measure : repeated-measures correlation coefficient

From before neuraxial block placement until 30 minutes after delivery.
Change in Perfusion Index associated with catheter malposition
Zeitfenster: From before neuraxial block placement until 30 minutes after delivery.

Magnitude of the change in PI (%) around events of epidural catheter malposition. Malposition is identified clinically by the need for catheter depth adjustment or replacement.

Unit of Measure - Perfusion Index (%)

From before neuraxial block placement until 30 minutes after delivery.
Change in Perfusion Index associated with sacral sparing in the second stage of labor
Zeitfenster: From before neuraxial block placement until 30 minutes after delivery.

Magnitude of the change in PI (%) in cases of sacral sparing, identified clinically by inadequate sacral analgesia in the second stage of labor (cold sensation test and NRS > 4 in the sacral distribution).

Unit of Measure - Perfusion Index (%)

From before neuraxial block placement until 30 minutes after delivery.
Perfusion Index across maternal body positions during epidural labor analgesia
Zeitfenster: From before neuraxial block placement until 30 minutes after delivery.

Peripheral Perfusion Index (%) recorded in the maternal body positions adopted during labor (e.g., supine with lateral tilt, lateral decubitus, sitting), to describe the effect of body position on PI.

Unit of Measure - Perfusion Index (%)

From before neuraxial block placement until 30 minutes after delivery.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

15. September 2026

Primärer Abschluss (Geschätzt)

31. Oktober 2027

Studienabschluss (Geschätzt)

31. Oktober 2027

Studienanmeldedaten

Zuerst eingereicht

8. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. September 2026

Zuerst gepostet (Tatsächlich)

21. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

21. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

16. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren